The BGF World Healthscience Fund aims to capitalize precisely this opportunity, by investing in companies that will give you access to potential long-term global growth themes through dynamic healthcare investing by industry experts.

Longer term we are optimistic about the outlook for healthcare, particularly given the secular trends that underpin the sector, such as an aging global population and rising emerging market middle class that will demand more extensive drug treatments and medical care.

Interview with Lead Portfolio Manager Erin Xie on the strategic approach.

Interview with Lead Portfolio Manager Erin Xie: update on Covid'19 and healthscience